New findings from the Children’s Medical Center Research Institute at UT Southwestern suggest that cancer cells utilize fat-packed molecules from the bloodstream as a means of survival, equipping themselves with antioxidants that allow them to evade cell death.
Published in the journal Nature, the study has unveiled a mechanism by which tumors access lipoproteins, molecules that transport fats and fat-soluble nutrients like vitamin E. Through sugar-coated structures on their surfaces called sulfated glycosaminoglycans (GAGs), cancer cells effectively fortify their membranes with vitamin E, thereby avoiding ferroptosis, a form of cell death driven by iron and oxidative stress.
Dr. Shad Thaxton, an associate professor of urology at Northwestern University’s Feinberg School of Medicine, expressed that understanding cancer’s metabolism could lead to novel therapeutic avenues, emphasizing the significance of ferroptosis as a potential mechanism to kill cancer cells. This metabolic rewiring is crucial for tumors that thrive on disrupted nutrient environments as they grow uncontrollably, said Javier Garcia-Bermudez, the study’s lead researcher.
It is theorized that cancers must acquire cellular building blocks, including lipids, to maintain their proliferation and growth. Lipids are vital components of cell membranes, and as tumors expand, they must either produce lipids or extract them from their surrounding environment. Garcia-Bermudez indicated that recent studies have widened the understanding of lipids’ role in cancer beyond just structural necessity, suggesting they may also help cancer cells avoid detection by the immune system.
The relationship between lipids and ferroptosis is intricate, with cancer cells often generating more oxidants than regular cells. Ferroptosis occurs when toxic oxidants accumulate, damaging cellular membranes and leading to cell death. Understanding how some cancers resist this process could inform therapeutic strategies aimed at leveraging ferroptosis in cancer treatment.
The researchers embarked on a detailed exploration of this phenomenon, beginning with the identification of key metabolic genes associated with cancer. They found that an enzyme called glutathione peroxidase 4 plays a significant role in managing lipid integrity and ferroptosis resistance in cancer cells. Deleting this enzyme led to the death of cancer cells unless they were provided with lipoproteins or treated with drugs that inhibit ferroptosis.
This observation prompted further investigation into the relationship between lipoproteins and ferroptosis. It was discovered that cancer cells actively sequester lipoproteins, particularly those rich in vitamin E, using GAGs to enhance their survival. By disrupting the synthesis of GAGs in experimental settings, Garcia-Bermudez and his team observed an increase in ferroptosis susceptibility among lab-grown cancer cells.
Moreover, analysis of human tumors from patients with clear cell renal carcinoma revealed high levels of GAGs and vitamin E, approximately 15 times higher than normal kidney tissue. This finding indicates that cancer cells actively metabolize vitamin E to survive, reinforcing the potential for therapies aimed at disrupting this pathway.
However, both Garcia-Bermudez and Dr. Ralph DeBerardinis, co-author of the study, emphasize that the road from these findings to therapeutic applications remains long. The precise mechanisms through which GAGs facilitate vitamin E uptake in cancer cells require further clarification, and understanding these mechanisms could lead to the development of targeted treatments.
DeBerardinis noted that initial findings do not establish any link between dietary vitamin E and cancer risk or outcomes, flagging this as an area for future research. There is potential to explore associations between GAG levels in tumors and patient prognoses, including treatment responses and survival rates, contributing to personalized care approaches.
Ferroptosis, as a targeted mechanism for cancer treatment, remains a field of active exploration. Thaxton’s team at Northwestern is pursuing synthetic versions of lipoproteins that lack lipid contents, envisioning these as agents that would mislead cancer cells and push them toward ferroptosis.
While promising, the study by Garcia-Bermudez and DeBerardinis encapsulates a foundational discovery in cancer metabolism research. As new insights unfold, the hope is that these findings can be translated into effective treatment modalities that exploit cancer’s metabolic vulnerabilities.
In conclusion, the research offers a glimpse into the complex interplay between cancer metabolism and cell death, highlighting the importance of continued investigation in this critical area of cancer biology. As researchers unravel the mechanics of tumors’ resource acquisition and their resistance to therapeutic interventions, they may uncover novel strategies for treating cancer more effectively.
image source from：dallasnews
